MYD88 and myeloid sarcoma: Plasmacytoid dendritic cells (pDCs) were identified as the main cell type upregulating TLR7 and MyD88 protein in response to interferon-β and TLR7 was increased in pDCs of interferon-β-treated patients with MS.